Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia. [electronic resource] by
- Martins, L R
- Lúcio, P
- Melão, A
- Antunes, I
- Cardoso, B A
- Stansfield, R
- Bertilaccio, M T S
- Ghia, P
- Drygin, D
- Silva, M G
- Barata, J T
Producer: 20140306
In:
Leukemia vol. 28
Availability: No items available.
|
|
7.
|
FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2. [electronic resource] by
- Fleskens, V
- Mokry, M
- van der Leun, A M
- Huppelschoten, S
- Pals, C E G M
- Peeters, J
- Coenen, S
- Cardoso, B A
- Barata, J T
- van Loosdregt, J
- Coffer, P J
Producer: 20170901
In:
Oncogene vol. 35
Availability: No items available.
|